Call for Grant Applications – New Investigator Research Grant Program
Application Deadline:
April 25, 2025
About Organisation
The Leukemia Research Foundation is dedicated to funding innovative research to advance the understanding, treatment, and potential cure of leukemia. With a commitment to supporting individual investigators and collaborative projects, the foundation prioritizes research initiatives that hold promise for impacting leukemia treatment and diagnosis. Its New Investigator Research Grant Program provides critical support to early-career researchers in the field of leukemia research, fostering creativity and innovation among promising scientists. The Foundation’s approach emphasizes the inclusion of underrepresented communities, diverse institutions, and varied geographic regions to enhance the overall impact of its research initiatives. Through these programs, the Foundation aims to propel breakthroughs in leukemia research, ultimately contributing to improved patient outcomes and advancing scientific knowledge in hematologic oncology.
About the Grant
The Leukemia Research Foundation’s New Investigator Research Grant Program supports early-career scientists conducting novel research in leukemia and myelodysplastic syndromes (MDS). Targeting new investigators within seven years of their first faculty-level position, the program provides grants up to $150,000 over two years to fund research that may lead to groundbreaking insights into leukemia. This funding cycle opens July 1, 2024, with a phased application process starting in December 2024. The grant is intended to cover research costs excluding major capital equipment and principal investigator salary, with a cap of $3,000 on research travel. The Leukemia Research Foundation encourages applications from researchers who reflect the diverse backgrounds of the research community.
Who can Apply?
Eligible applicants are new, independent investigators at nonprofit academic institutions and within seven years of their first faculty-level position. Candidates must have an independent laboratory and the ability to oversee research personnel and project decisions. Time spent in training roles, such as postdoctoral fellowships or residencies, is excluded from the seven-year limit. The program accommodates career interruptions, which applicants must document in their application. Non-U.S. applicants are eligible, as are researchers with specific grant types (KO8, R00, R99) under the $175,000 annual direct cost limit. However, researchers with NIH RO1 funding, VA Merit Awards, or total annual direct funding exceeding $175,000 are ineligible. Former Leukemia Research Foundation grant recipients and fellows are also not eligible.
How to Apply?
Submit a Letter of Intent (LOI) through ProposalCentral. If selected, the Foundation will invite you to submit a full application via the same platform. The LOI submission begins December 6, 2024, and closes on February 14, 2025.
Application Deadline
The deadline for full applications (if invited) is April 25, 2025, by 12pm CT.
Last Date To Apply
For more information, please visit the grant website here.
